Stratus Medical Initiates Enrolment of Participants for Nimbus RF Device Clinical Trial

Source Node: 2418939

Stratus Medical, a medical device company, recently announced the initiation of enrolment for their clinical trial of the Nimbus RF device. This device is a minimally invasive, non-surgical treatment for chronic pain. It is designed to provide targeted relief to patients suffering from chronic pain in the lower back, neck, and shoulders.

The clinical trial will involve a total of 30 participants who will receive the Nimbus RF device. The participants will be monitored over a period of 12 weeks to assess the safety and efficacy of the device. The study will also evaluate the device’s ability to reduce pain, improve quality of life, and reduce the need for opioid medications.

The Nimbus RF device works by delivering radiofrequency energy to the affected area. This energy is designed to reduce inflammation and stimulate the body’s natural healing process. It is a safe and effective treatment option for those who suffer from chronic pain and have not responded to other treatments.

The clinical trial is an important step in the development of the Nimbus RF device. It will provide valuable data on the safety and efficacy of the device and help Stratus Medical determine if it is suitable for widespread use. The results of the trial will be used to inform future decisions regarding the device’s availability and use.

Stratus Medical is committed to providing safe and effective treatments for those suffering from chronic pain. The initiation of enrolment for the Nimbus RF device clinical trial is an important step in their mission to improve the quality of life for those living with chronic pain.

Source: Plato Data Intelligence: PlatoAiStream